Certified by Founder Lodge
Basking Biosciences Inc
United States - Columbus, OH
START UP
1 Disclosed Funding Rounds $55,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Basking is developing the first in class agent (BB-031) targeting von Willebrand Factor (VWF) along with a direct acting reversal agent (BB-025) to immediately the pharmacological effect of B
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 02 ,2024 | Unknown | $55,000,000 |
Solas BioVentures
RTW Investments, LP
Rev1 Ventures
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
